These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 8808110

  • 1. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children.
    Lieberman KV, Tejani A.
    J Am Soc Nephrol; 1996 Jan; 7(1):56-63. PubMed ID: 8808110
    [Abstract] [Full Text] [Related]

  • 2. Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study.
    Soliman AR, Maamoun H, Soliman H, Ahmed RM.
    Rom J Intern Med; 2021 Jun 01; 59(2):127-133. PubMed ID: 33565308
    [Abstract] [Full Text] [Related]

  • 3. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis.
    Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A.
    J Am Soc Nephrol; 1995 Apr 01; 5(10):1820-5. PubMed ID: 7787150
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
    Chiou YY, Lee YC, Chen MJ.
    Curr Med Res Opin; 2017 Aug 01; 33(8):1389-1399. PubMed ID: 28436233
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
    Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL.
    Kidney Int; 1999 Dec 01; 56(6):2220-6. PubMed ID: 10594798
    [Abstract] [Full Text] [Related]

  • 6. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
    Heering P, Braun N, Müllejans R, Ivens K, Zäuner I, Fünfstück R, Keller F, Krämer BK, Schollmeyer P, Risler T, Grabensee B, German Collaborative Glomerulonephritis Study Group.
    Am J Kidney Dis; 2004 Jan 01; 43(1):10-8. PubMed ID: 14712422
    [Abstract] [Full Text] [Related]

  • 7. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
    Nephrol Dial Transplant; 2005 Apr 01; 20(4):735-42. PubMed ID: 15772265
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov 01; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 9. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis.
    Ittel TH, Clasen W, Fuhs M, Kindler J, Mihatsch MJ, Sieberth HG.
    Clin Nephrol; 1995 Sep 01; 44(3):156-62. PubMed ID: 8556831
    [Abstract] [Full Text] [Related]

  • 10. Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis.
    Shatat IF, Schoeneman M, Flynn JT, Woroniecki RP.
    Pediatr Nephrol; 2007 Jun 01; 22(6):834-9. PubMed ID: 17294224
    [Abstract] [Full Text] [Related]

  • 11. Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Plank C, Kalb V, Hinkes B, Hildebrandt F, Gefeller O, Rascher W, Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Pediatr Nephrol; 2008 Sep 01; 23(9):1483-93. PubMed ID: 18481113
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of losartan in patients with primary focal segmental glomerulosclerosis resistant to immunosuppressive treatment.
    Usta M, Ersoy A, Dilek K, Ozdemir B, Yavuz M, Güllülü M, Yurtkuran M.
    J Intern Med; 2003 Mar 01; 253(3):329-34. PubMed ID: 12603500
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May 01; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 14. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults.
    Braun N, Schmutzler F, Lange C, Perna A, Remuzzi G, Risler T, Willis NS.
    Cochrane Database Syst Rev; 2008 Jul 16; 2008(3):CD003233. PubMed ID: 18646090
    [Abstract] [Full Text] [Related]

  • 15. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
    Troost JP, Trachtman H, Spino C, Kaskel FJ, Friedman A, Moxey-Mims MM, Fine RN, Gassman JJ, Kopp JB, Walsh L, Wang R, Gipson DS.
    Am J Kidney Dis; 2021 Feb 16; 77(2):216-225. PubMed ID: 32791086
    [Abstract] [Full Text] [Related]

  • 16. Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis.
    Cattran D, Neogi T, Sharma R, McCarthy ET, Savin VJ.
    J Am Soc Nephrol; 2003 Feb 16; 14(2):448-53. PubMed ID: 12538746
    [Abstract] [Full Text] [Related]

  • 17. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children.
    Hattori M, Chikamoto H, Akioka Y, Nakakura H, Ogino D, Matsunaga A, Fukazawa A, Miyakawa S, Khono M, Kawaguchi H, Ito K.
    Am J Kidney Dis; 2003 Dec 16; 42(6):1121-30. PubMed ID: 14655182
    [Abstract] [Full Text] [Related]

  • 18. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
    Duncan N, Dhaygude A, Owen J, Cairns TD, Griffith M, McLean AG, Palmer A, Taube D.
    Nephrol Dial Transplant; 2004 Dec 16; 19(12):3062-7. PubMed ID: 15507477
    [Abstract] [Full Text] [Related]

  • 19. A partial response to abatacept in a patient with steroid resistant focal segmental glomerulosclerosis.
    Soyaltın E, Demir BK, Alparslan C, Çamlar SA, Alaygut D, Yavaşcan Ö, Mutlubaş F.
    Turk J Pediatr; 2020 Dec 16; 62(4):663-667. PubMed ID: 32779421
    [Abstract] [Full Text] [Related]

  • 20. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
    El-Reshaid K, El-Reshaid W, Madda J.
    Ren Fail; 2005 Dec 16; 27(5):523-30. PubMed ID: 16152989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.